PMC:7200337 / 99543-99728 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T753","span":{"begin":61,"end":68},"obj":"Body_part"}],"attributes":[{"id":"A753","pred":"fma_id","subj":"T753","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Finally, another approach to nAb development is to fuse ACE2 protein and the Fc part of antibodies, as they would bind RBD and potentially be crossreactive among other CoVs (Figure 6D)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1036","span":{"begin":77,"end":79},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Finally, another approach to nAb development is to fuse ACE2 protein and the Fc part of antibodies, as they would bind RBD and potentially be crossreactive among other CoVs (Figure 6D)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T322","span":{"begin":61,"end":68},"obj":"Chemical"}],"attributes":[{"id":"A322","pred":"chebi_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Finally, another approach to nAb development is to fuse ACE2 protein and the Fc part of antibodies, as they would bind RBD and potentially be crossreactive among other CoVs (Figure 6D)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3276","span":{"begin":56,"end":60},"obj":"Gene"},{"id":"3295","span":{"begin":168,"end":172},"obj":"Species"},{"id":"3300","span":{"begin":29,"end":32},"obj":"Chemical"}],"attributes":[{"id":"A3276","pred":"tao:has_database_id","subj":"3276","obj":"Gene:59272"},{"id":"A3295","pred":"tao:has_database_id","subj":"3295","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Finally, another approach to nAb development is to fuse ACE2 protein and the Fc part of antibodies, as they would bind RBD and potentially be crossreactive among other CoVs (Figure 6D)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T583","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, another approach to nAb development is to fuse ACE2 protein and the Fc part of antibodies, as they would bind RBD and potentially be crossreactive among other CoVs (Figure 6D)."}